Some clinicians are convinced that antiphospholipid antibodies, includ
ing antibodies to any one of five-to-seven phospholipid antigens, are
associated with infertility. Additionally, some clinicians recommend t
hat infertile women who have antiphospholipid antibodies and are under
going in-vitro fertilization should be treated with heparin to improve
the rate of pregnancy. However, experts disagree regarding the relati
onship between antiphospholipid antibodies and infertility. There is a
lso substantial evidence that treatment with heparin does not alter th
e rate of pregnancy following in-vitro fertilization. Why the confusio
n? Probable culprits include variation in study design and the selecti
on of infertile patients. Another important problem is that assays for
antiphospholipid antibodies other than anticardiolipin are not standa
rdized. Before the real relationship between antiphospholipid antibodi
es and infertility is discovered, assays for antiphospholipid antibodi
es other than anticardiolipin must be standardized and properly design
ed studies conducted. Randomized, controlled trials must be done to de
termine if heparin should be recommended as an adjunctive treatment fo
r in-vitro fertilization in women with antiphospholipid antibodies.